Maravai Lifesciences Holdings, Inc.
MRVI
Revenue
73.40M
▲9.22M▲14.37%
3 Months ChangeAssets
1.45B
▲2.97M▲0.2054%
3 Months ChangeLiabilities
671.19M
▲3.94M▲0.5908%
3 Months ChangeFree Cash Flow
-14.13M
▼-91.34M▼-118.30%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001823239-24-000100
2024-08-08
Form 10-Q
ID: 0001823239-24-000095
2024-08-07
Form 8-K
ID: 0001823239-24-000093
2024-07-29
Form 8-K
ID: 0001823239-24-000091
2024-06-12
Form 8-K
ID: 0001823239-24-000084
2024-05-28
Form 8-K
ID: 0001823239-24-000082
2024-05-09
Form 10-Q
ID: 0001823239-24-000060
2024-05-08
Form 8-K
ID: 0001823239-24-000058
2024-02-22
Form 8-K
ID: 0001823239-24-000028
2023-11-08
Form 10-Q
ID: 0001823239-23-000089